Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns
Study 126 cards on 30 common drug classes: mechanisms, qualified generic-name patterns, common uses, and major safety concepts for nursing and introductory health science.
Über dieses Lernkartenset
Build a durable pharmacology map with 126 independently authored cards. Six prerequisites define drug classes, mechanisms, agonism, antagonism, inhibition, and how to treat generic-name stems as fallible clues. The remaining 120 cards cover 30 common classes through four separate retrieval directions: class → core mechanism; qualified pattern or representative generics → class; class → common use; and class → major safety concept.
The deck deliberately excludes dosing, prescribing, patient-specific guidance, administration or hold parameters, exhaustive contraindications and interactions, monitoring protocols, brand names, official questions, and clinical cases. Generic-name patterns are clues, never universal rules. Use this deck for study—not clinical decision-making.
Ordering supports learning: prerequisites come first, then five spiral blocks mix six broad topic groups. Same-class variants stay at least three unrelated cards apart, alternating mechanism, recognition, common-use, and safety recall instead of forming predictable runs.
Open Study Contributor independently authored this standalone deck from common pharmacology knowledge checked against WHO, FDA, and NIH/NCBI sources. Organization names identify sources only; no affiliation or endorsement is claimed.
Karten in diesem Lernkartenset
Karte 1
Frage
What is a drug class?
Antwort
A group of drugs linked by a shared mechanism, target, structure, therapeutic use, or a combination of these features.
Karte 2
Frage
What does mechanism of action mean?
Antwort
How a drug produces its effects at a molecular, cellular, or physiological target.
Karte 3
Frage
What is a receptor agonist?
Antwort
A drug that binds to a receptor and activates it to produce a response.
Karte 4
Frage
What is a receptor antagonist?
Antwort
A drug that binds to a receptor and blocks or reduces activation by an agonist.
Karte 5
Frage
What does it mean when a drug inhibits an enzyme or transporter?
Antwort
It reduces that protein's activity, changing the movement or conversion of its usual substrates.
Karte 6
Frage
How should generic-name stems be used to recognize drug classes?
Antwort
As clues, not universal rules. Confirm the actual drug because exceptions and overlapping stems exist.
Karte 7
Frage
ACE inhibitors: core mechanism?
Antwort
They inhibit angiotensin-converting enzyme, reducing angiotensin II and aldosterone while increasing bradykinin.
Karte 8
Frage
SSRIs: core mechanism?
Antwort
They inhibit the serotonin transporter, increasing serotonin signaling in the synaptic cleft.
Karte 9
Frage
Biguanides: core mechanism?
Antwort
Metformin mainly reduces hepatic glucose production and improves insulin sensitivity without directly stimulating insulin release.
Karte 10
Frage
Penicillins: core mechanism?
Antwort
Their beta-lactam ring binds penicillin-binding proteins and disrupts bacterial cell-wall synthesis.
Karte 11
Frage
Which class is often suggested by the ending -pril?
Antwort
ACE inhibitors. Examples include lisinopril and enalapril, but a name stem is only a clue.
Karte 12
Frage
Proton-pump inhibitors: core mechanism?
Antwort
They inhibit the H+/K+ ATPase proton pump in gastric parietal cells, strongly reducing acid secretion.
Karte 13
Frage
SSRIs: common uses?
Antwort
Depression and several anxiety-related disorders; the approved indications differ by agent.
Karte 14
Frage
NSAIDs: core mechanism?
Antwort
They inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis.
Karte 15
Frage
Biguanides: major safety concepts?
Antwort
Gastrointestinal effects are common; vitamin B12 can fall with long use, and lactic acidosis is rare but serious.
Karte 16
Frage
Which class is often suggested by the ending -cillin?
Antwort
Penicillins, such as amoxicillin and piperacillin. The stem does not describe spectrum or resistance.
Karte 17
Frage
ACE inhibitors: common uses?
Antwort
Hypertension and selected heart-failure, post-myocardial-infarction, and kidney-protection indications.
Karte 18
Frage
Proton-pump inhibitors: major safety concepts?
Antwort
Possible concerns include hypomagnesemia and enteric infection risk. Many other long-term links are observational rather than proven causal effects.
Karte 19
Frage
Which class is often suggested by -oxetine or -opram?
Antwort
SSRIs, but not universally. Sertraline and fluvoxamine are exceptions, and some stems overlap other classes.
Karte 20
Frage
NSAIDs: common uses?
Antwort
Pain, inflammation, and fever; individual agents also have more specific uses.
Karte 21
Frage
Metformin belongs to which drug class?
Antwort
Biguanides. Metformin is the main widely used member, so there is no useful class-wide suffix rule.
Karte 22
Frage
Penicillins: major safety concepts?
Antwort
Hypersensitivity can range from rash to anaphylaxis; diarrhea and antibiotic-associated colitis are additional concerns.
Karte 23
Frage
ACE inhibitors: major safety concepts?
Antwort
Cough, hyperkalemia, kidney-function changes, angioedema, and fetal harm are major class concerns.
Karte 24
Frage
Proton-pump inhibitors: common uses?
Antwort
Acid-related disorders such as GERD, erosive esophagitis, and peptic-ulcer disease.
Karte 25
Frage
SSRIs: major safety concepts?
Antwort
Serotonin syndrome, bleeding and hyponatremia risks, sexual dysfunction, and the antidepressant suicidality warning for younger people.
Karte 26
Frage
Ibuprofen, naproxen, and ketorolac belong to which class?
Antwort
NSAIDs. The class has no single reliable generic-name suffix.
Karte 27
Frage
Biguanides: common use?
Antwort
Type 2 diabetes.
Karte 28
Frage
Penicillins: common use?
Antwort
Treatment of susceptible bacterial infections; the spectrum differs substantially among individual penicillins.
Karte 29
Frage
Which class is often suggested by the ending -prazole?
Antwort
Proton-pump inhibitors, such as omeprazole and pantoprazole. Confirm the individual drug.
Karte 30
Frage
NSAIDs: major safety concepts?
Antwort
Gastrointestinal bleeding, kidney injury, fluid retention, and cardiovascular events are key risks; FDA also warns about use from about 20 weeks of pregnancy.
Karte 31
Frage
Sulfonylureas: core mechanism?
Antwort
They close ATP-sensitive potassium channels in pancreatic beta cells, triggering insulin release even when glucose is not high.
Karte 32
Frage
H2 blockers: core mechanism?
Antwort
They competitively block histamine H2 receptors on gastric parietal cells, reducing acid secretion.
Karte 33
Frage
SNRIs: core mechanism?
Antwort
They inhibit serotonin and norepinephrine reuptake transporters, increasing both transmitters in synapses.
Karte 34
Frage
Opioid analgesics: core mechanism?
Antwort
They activate opioid receptors; many important analgesic effects and toxicities are mediated through mu receptors.
Karte 35
Frage
Glipizide, glyburide, and glimepiride belong to which class?
Antwort
Sulfonylureas. Their names offer clues, but the broad ending -ide is not class-specific.
Karte 36
Frage
ARBs: core mechanism?
Antwort
They block angiotensin II at AT1 receptors, reducing vasoconstriction and aldosterone effects.
Karte 37
Frage
H2 blockers: common uses?
Antwort
Acid-related disorders such as heartburn, GERD, and gastric or duodenal ulcers.
Karte 38
Frage
Cephalosporins: core mechanism?
Antwort
Their beta-lactam ring binds penicillin-binding proteins and disrupts bacterial cell-wall synthesis.
Karte 39
Frage
SNRIs: major safety concepts?
Antwort
Serotonin syndrome, blood-pressure increases, discontinuation symptoms, and the antidepressant suicidality warning for younger people.
Karte 40
Frage
Morphine, oxycodone, and fentanyl belong to which broad class?
Antwort
Opioid analgesics. The class has no single reliable generic-name suffix.
Karte 41
Frage
Sulfonylureas: common use?
Antwort
Type 2 diabetes when increasing pancreatic insulin release is appropriate.
Karte 42
Frage
ARBs: major safety concepts?
Antwort
Hyperkalemia, hypotension, kidney-function changes, and fetal harm are major concerns; cough is less common than with ACE inhibitors.
Karte 43
Frage
Which class is often suggested by the ending -tidine?
Antwort
H2 receptor blockers, such as famotidine and cimetidine. Confirm the individual drug.
Karte 44
Frage
Cephalosporins: common use?
Antwort
Treatment of susceptible bacterial infections; antibacterial spectrum varies widely by agent and generation.
Karte 45
Frage
Which name endings can suggest an SNRI?
Antwort
-faxine or sometimes -oxetine, but neither is decisive. The -oxetine ending also appears in some SSRIs.
Karte 46
Frage
Opioid analgesics: major safety concepts?
Antwort
Respiratory depression, sedation, constipation, tolerance, dependence, and overdose; benzodiazepines and other depressants increase danger.
Karte 47
Frage
Sulfonylureas: major safety concepts?
Antwort
Hypoglycemia and weight gain are the main class patterns, with risk differing among agents and clinical contexts.
Karte 48
Frage
ARBs: common uses?
Antwort
Hypertension and selected heart-failure and kidney-protection indications.
Karte 49
Frage
H2 blockers: major safety concepts?
Antwort
They are usually well tolerated, but confusion or other CNS effects can occur with reduced clearance; cimetidine has many interactions.
Karte 50
Frage
Which class is often suggested by cef- or ceph-?
Antwort
Cephalosporins, such as cefazolin and cephalexin. The name does not reveal the full spectrum.
Karte 51
Frage
SNRIs: common uses?
Antwort
Depression and anxiety disorders; selected agents also treat neuropathic pain or fibromyalgia.
Karte 52
Frage
Opioid analgesics: common uses?
Antwort
Analgesia for selected severe pain and perioperative settings; individual opioids also have other specific uses.
Karte 53
Frage
Which class is often suggested by the ending -sartan?
Antwort
Angiotensin II receptor blockers, or ARBs. Examples include losartan and valsartan.
Karte 54
Frage
Cephalosporins: major safety concepts?
Antwort
Hypersensitivity and antibiotic-associated diarrhea are important; penicillin cross-reactivity depends largely on similar side chains.
Karte 55
Frage
Beta2 agonists: core mechanism?
Antwort
They activate beta2 receptors, increasing cAMP and relaxing airway smooth muscle.
Karte 56
Frage
Beta blockers: core mechanism?
Antwort
They antagonize beta-adrenergic receptors; beta1 blockade can reduce heart rate, contractility, and renin release.
Karte 57
Frage
Systemic corticosteroids: core mechanism?
Antwort
They bind intracellular glucocorticoid receptors and alter gene transcription, reducing inflammatory and immune signaling.
Karte 58
Frage
Benzodiazepines: core mechanism?
Antwort
They positively modulate GABA-A receptors, increasing the frequency of chloride-channel opening when GABA is present.
Karte 59
Frage
Which class is often suggested by the ending -terol?
Antwort
Beta2 agonist bronchodilators, such as formoterol and salmeterol. Albuterol is a familiar exception.
Karte 60
Frage
Macrolides: core mechanism?
Antwort
They bind the bacterial 50S ribosomal subunit and inhibit protein synthesis.
Karte 61
Frage
Beta blockers: common uses?
Antwort
Selected cardiovascular conditions such as arrhythmias, ischemic heart disease, heart failure, and hypertension; some agents have noncardiac uses.
Karte 62
Frage
GLP-1 receptor agonists: core mechanism?
Antwort
They activate GLP-1 receptors, increasing glucose-dependent insulin release, suppressing glucagon, and slowing gastric emptying.
Karte 63
Frage
Systemic corticosteroids: major safety concepts?
Antwort
Infection, hyperglycemia, osteoporosis, and hypothalamic-pituitary-adrenal suppression; risks rise with systemic exposure and duration.
126 Karten
Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns
Mit diesem Lernkartenset kostenlos lernenFlashcards wird geöffnet, damit du mit dem Lernen beginnen kannst.
Karte 64
Frage
Which endings often suggest a benzodiazepine?
Antwort
-azepam or -azolam, as in diazepam or midazolam. Not every sedative with a similar ending belongs to this class.
Karte 65
Frage
Beta2 agonists: common use?
Antwort
Bronchodilation in asthma or COPD regimens; short- and long-acting agents play different roles.
Karte 66
Frage
Macrolides: major safety concepts?
Antwort
Gastrointestinal effects, QT prolongation, and clinically important interactions that vary by agent.
Karte 67
Frage
Which class is often suggested by the ending -olol?
Antwort
Beta blockers, such as metoprolol and propranolol. Receptor selectivity still varies by agent.
Karte 68
Frage
GLP-1 receptor agonists: common uses?
Antwort
Type 2 diabetes; selected agents are also approved for chronic weight management and cardiovascular-risk reduction.
Karte 69
Frage
Which patterns often suggest a systemic corticosteroid?
Antwort
-sone or -olone, as in prednisone or prednisolone, but these endings are not unique to the class.
Karte 70
Frage
Benzodiazepines: major safety concepts?
Antwort
Sedation, dependence and withdrawal, plus respiratory depression—especially with opioids, alcohol, or other CNS depressants.
Karte 71
Frage
Beta2 agonists: major safety concepts?
Antwort
Tremor, palpitations or tachycardia, hypokalemia, and rare paradoxical bronchospasm.
Karte 72
Frage
Macrolides: common use?
Antwort
Treatment of selected susceptible bacterial infections, including some respiratory and atypical pathogens.
Karte 73
Frage
Beta blockers: major safety concepts?
Antwort
Bradycardia and hypotension; nonselective agents can cause bronchospasm, and the class can mask adrenergic signs of hypoglycemia.
Karte 74
Frage
Which class is often suggested by -glutide?
Antwort
GLP-1 receptor agonists, such as semaglutide and liraglutide. Exenatide and lixisenatide show the pattern is not universal.
Karte 75
Frage
Systemic corticosteroids: common uses?
Antwort
Inflammatory, allergic, and autoimmune disorders, with the route and agent chosen for the condition.
Karte 76
Frage
Benzodiazepines: common uses?
Antwort
Anxiety, seizures, procedural sedation, or alcohol withdrawal, depending on the agent and setting.
Karte 77
Frage
Which class is often suggested by the ending -thromycin?
Antwort
Macrolide antibiotics, such as azithromycin and clarithromycin. Confirm the individual agent.
Karte 78
Frage
GLP-1 receptor agonists: major safety concepts?
Antwort
Gastrointestinal effects are common; gallbladder disease and pancreatitis are warnings, and some labels warn about thyroid C-cell tumors.
Karte 79
Frage
Second-generation antipsychotics: core mechanism?
Antwort
Most modulate dopamine D2 and serotonin 5-HT2A signaling, but receptor profiles vary substantially by agent.
Karte 80
Frage
Tetracyclines: core mechanism?
Antwort
They bind the bacterial 30S ribosomal subunit and inhibit protein synthesis.
Karte 81
Frage
Dihydropyridine calcium-channel blockers: core mechanism?
Antwort
They block L-type calcium channels mainly in vascular smooth muscle, causing arteriolar relaxation.
Karte 82
Frage
Inhaled antimuscarinics: core mechanism?
Antwort
They block airway muscarinic receptors, reducing vagal bronchoconstriction and promoting bronchodilation.
Karte 83
Frage
Which endings often suggest a second-generation antipsychotic?
Antwort
-apine or -idone often appear, but many members use other endings and the stems are not class-specific.
Karte 84
Frage
SGLT2 inhibitors: core mechanism?
Antwort
They inhibit renal sodium-glucose cotransporter 2, increasing urinary glucose and sodium excretion.
Karte 85
Frage
Tetracyclines: common uses?
Antwort
Selected susceptible bacterial infections and, for some agents, acne or rosacea.
Karte 86
Frage
Bisphosphonates: core mechanism?
Antwort
They bind bone mineral and inhibit osteoclast-mediated bone resorption.
Karte 87
Frage
Dihydropyridine calcium-channel blockers: major safety concepts?
Antwort
Peripheral edema, flushing, headache, dizziness, and hypotension are characteristic patterns.
Karte 88
Frage
Which class is often suggested by the ending -tropium?
Antwort
Inhaled antimuscarinic bronchodilators, such as ipratropium and tiotropium. Several class members use other endings.
Karte 89
Frage
Second-generation antipsychotics: common uses?
Antwort
Schizophrenia and selected bipolar or other psychiatric indications; approvals differ by agent.
Karte 90
Frage
SGLT2 inhibitors: major safety concepts?
Antwort
Genital infections, volume depletion, ketoacidosis, and rare necrotizing infection of the perineum.
Karte 91
Frage
Which class is often suggested by the ending -cycline?
Antwort
Tetracycline antibiotics, such as doxycycline and minocycline. Confirm the individual drug.
Karte 92
Frage
Bisphosphonates: common uses?
Antwort
Osteoporosis and selected disorders with excessive bone resorption, including Paget disease or malignancy-related bone disease.
Karte 93
Frage
Which class is often suggested by the ending -dipine?
Antwort
Dihydropyridine calcium-channel blockers, such as amlodipine and nifedipine.
Karte 94
Frage
Inhaled antimuscarinics: major safety concepts?
Antwort
Dry mouth, urinary retention, tachycardia, and eye exposure that may worsen narrow-angle glaucoma.
Karte 95
Frage
Second-generation antipsychotics: major safety concepts?
Antwort
Metabolic effects, movement disorders, QT effects, and neuroleptic malignant syndrome; labels warn about increased mortality in elderly patients with dementia-related psychosis.
Karte 96
Frage
SGLT2 inhibitors: common uses?
Antwort
Type 2 diabetes; selected agents also treat heart failure or chronic kidney disease.
Karte 97
Frage
Tetracyclines: major safety concepts?
Antwort
Gastrointestinal or esophageal irritation, photosensitivity, and effects on developing teeth and bone are key patterns.
Karte 98
Frage
Which class is often suggested by the ending -dronate?
Antwort
Bisphosphonates, such as alendronate and risedronate. Confirm the individual agent and formulation.
Karte 99
Frage
Dihydropyridine calcium-channel blockers: common uses?
Antwort
Hypertension and angina, using vascular smooth-muscle relaxation to reduce arterial tone.
Karte 100
Frage
Inhaled antimuscarinics: common use?
Antwort
Maintenance bronchodilation, especially in COPD; selected agents also serve as add-on asthma therapy.
Karte 101
Frage
Which class is often suggested by the ending -gliflozin?
Antwort
SGLT2 inhibitors, such as empagliflozin and dapagliflozin.
Karte 102
Frage
Bisphosphonates: major safety concepts?
Antwort
Upper-GI irritation with oral agents, hypocalcemia, and rare osteonecrosis of the jaw or atypical femur fracture.
Karte 103
Frage
TNF inhibitors: core mechanism?
Antwort
They neutralize tumor necrosis factor signaling, reducing downstream inflammation.
Karte 104
Frage
DPP-4 inhibitors: core mechanism?
Antwort
They inhibit DPP-4, prolonging endogenous incretin activity and increasing glucose-dependent insulin release.
Karte 105
Frage
Inhaled corticosteroids: core mechanism?
Antwort
They activate glucocorticoid receptors in airway cells, reducing inflammatory gene expression and airway inflammation.
Karte 106
Frage
Statins: core mechanism?
Antwort
They inhibit HMG-CoA reductase, reducing hepatic cholesterol synthesis and increasing hepatic LDL-receptor activity.
Karte 107
Frage
Adalimumab, infliximab, and etanercept belong to which class?
Antwort
TNF inhibitors. The class has no single specific shared suffix: -mab is broad, and etanercept ends in -cept.
Karte 108
Frage
Triptans: core mechanism?
Antwort
They activate serotonin 5-HT1B/1D receptors, reducing trigeminal signaling and causing cranial vasoconstriction.
Karte 109
Frage
DPP-4 inhibitors: common use?
Antwort
Type 2 diabetes, using enhanced endogenous incretin signaling to improve glucose-dependent insulin release.
Karte 110
Frage
Fluoroquinolones: core mechanism?
Antwort
They inhibit bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication.
Karte 111
Frage
Inhaled corticosteroids: major safety concepts?
Antwort
Oral candidiasis and dysphonia are important local effects; systemic effects become more relevant with higher exposure.
Karte 112
Frage
Which class is suggested by the ending -statin?
Antwort
HMG-CoA reductase inhibitors, or statins, such as atorvastatin and rosuvastatin.
Karte 113
Frage
TNF inhibitors: common uses?
Antwort
Selected autoimmune inflammatory diseases, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis-related conditions.
Karte 114
Frage
Triptans: major safety concepts?
Antwort
Vasoconstrictive risk in coronary, cerebrovascular, or peripheral vascular disease, plus tingling, flushing, or chest pressure called triptan sensations.
Karte 115
Frage
Which class is suggested by the ending -gliptin?
Antwort
DPP-4 inhibitors, such as sitagliptin and linagliptin.
Karte 116
Frage
Fluoroquinolones: common use?
Antwort
Selected serious or resistant bacterial infections when their spectrum and risk profile fit the infection.
Karte 117
Frage
Which patterns often suggest an inhaled corticosteroid?
Antwort
-sonide or -sone often appear, as in budesonide or fluticasone, but these endings are not class-specific.
Karte 118
Frage
Statins: major safety concepts?
Antwort
Muscle symptoms and rare rhabdomyolysis or liver injury; pregnancy is a major risk context, although FDA no longer applies a blanket class contraindication.
Karte 119
Frage
TNF inhibitors: major safety concepts?
Antwort
Serious infections and reactivation of tuberculosis or hepatitis B are central concerns; other warnings vary by agent.
Karte 120
Frage
Triptans: common use?
Antwort
Acute treatment of migraine attacks; they are not general-purpose analgesics or routine migraine preventives.
Karte 121
Frage
DPP-4 inhibitors: major safety concepts?
Antwort
Severe joint pain and pancreatitis are warnings; some agents also carry a heart-failure warning.
Karte 122
Frage
Which class is suggested by the ending -floxacin?
Antwort
Fluoroquinolone antibiotics, such as ciprofloxacin and levofloxacin.
Karte 123
Frage
Inhaled corticosteroids: common use?
Antwort
Controller therapy for asthma and selected COPD regimens; they reduce inflammation rather than acting as standalone rescue bronchodilators.
Karte 124
Frage
Statins: common uses?
Antwort
Lowering LDL cholesterol and reducing atherosclerotic cardiovascular risk.
Karte 125
Frage
Which class is suggested by the ending -triptan?
Antwort
Triptan antimigraine agents, such as sumatriptan and rizatriptan.
Karte 126
Frage
Fluoroquinolones: major safety concepts?
Antwort
Potentially disabling tendon, muscle, joint, nerve, and CNS effects, plus a rare risk of aortic aneurysm or rupture in susceptible people.
126 Karten
Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns
Flashcards wird geöffnet, damit du mit dem Lernen beginnen kannst.